PCI Pharma Services has acquired Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based ...

Along with PCI's own robust infrastructure expansions, acquisition furthers CDMO's recent growth in sterile fill-finish, advanced drug delivery ...

The global lung cancer therapeutics market is on a robust growth trajectory, poised to witness a significant transformation over the next decade. According to recent market projections, the industry ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as ...

SMi Group reports: Alina Alexeenko of Purdue University presenting LyoHub's overview and strategies for the future of lyophilization and alternatives to conventional methods Optimization of ...

Xellia Pharmaceuticals, the largest and last maker of key antibiotics APIs in Europe, will shutter its Copenhagen production facility in a move seen as a blow to EU reshoring efforts.

11 NEWS AT FIVE CONTINUES. WHEN SOMEONE TESTS POSITIVE FOR FENTANYL, YOU’LL ALMOST ALWAYS FIND ANOTHER DRUG. AND IN MARYLAND AND MANY OTHER STATES, WHAT YOU FIND IS COCAINE. THIS JUST ONE ...

Exclusive-WHO to Back Use of Weight-Loss Drugs for Adults Globally, Raises Cost Issue By Jennifer Rigby LONDON (Reuters) -The World Health Organization plans to officially back the use of weight ...